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As elective ophthalmic services prepare to resume after the Government lockdown of 23rd March and cessation of elective ophthalmic care on 28th March, measures are being planned to protect patients and professionals from exposure to Covid-19. These include isolating and swab testing patients for PCR before admission. A review of the performance of several PCR tests for Covid-19 showed false negative rates from 2% to 29% \[[@CR1]\] raising concerns that potentially infectious but asymptomatic patients might go undetected.

We have developed a tool to calculate the probability of encountering an asymptomatic Covid-19 patient missed by PCR-based swab testing, using information on the known sensitivity (detection rate) and estimated specificity (1---false positive rate) of the diagnostic test, but also using information on the prevalence of disease \[[@CR2]\], which is essential to calculate the predictive value of a positive or negative test. This is available on <https://tinyurl.com/y7k2hdod> ([Supplementary Material](#MOESM1){ref-type="media"}).

To estimate the prevalence of Covid-19 we utilized a real-time database of self-reported symptoms captured through mobile phones. While not without limitations, these estimates have been validated against the results of swab testing and have predicted spikes of infection several days before they were detected \[[@CR3]\]. Regional level data are published live at <https://covid.joinzoe.com/data>. Because this approach misses asymptomatic carriers, attempts to determine the percentage of these are based on analysis of passengers on repatriation flights, holiday makers confined on the Diamond Princess cruise ship, contact tracing in South Korea, an outbreak amongst American care home residents \[[@CR4]\], and random sampling of Iceland's population \[[@CR5]\]. These studies estimate the rate of asymptomatic infection to be 49.8% (95% CI: 46.1--53.5%). This percentage encompasses those who are asymptomatic throughout the disease and those who are presymptomatic. In preoperatively isolated patients, the disease will become manifest or pass in a proportion of them.

For example, on 28th May the estimated Covid-19 prevalence for Bristol was 0.6%. With an asymptomatic rate of 49.8%, the prevalence of asymptomatic Covid-19 would be 0.3%, giving an overall prevalence of 0.9%. Assuming a Covid-19 PCR test has a 71% detection rate (29% false negative rate), and that the detection rate does not differ among those who are symptomatic or not, the proportion of individuals with a negative test without infection (the negative predictive value) would be 99.7% (Table [1](#Tab1){ref-type="table"}) and with infection (1-NPV) would be 0.3%. Of these, under one-third would be asymptomatic. In other words, to encounter one PCR-negative asymptomatic Covid-19 patient, we would need to assess 1135 patients.Table 1Binary classification table of symptomatic and asymptomatic Covid-19 patients by PCR testing characteristics for a symptomatic prevalence of 0.6%, asymptomatic rate of 49.8%, detection rate of 71%, and false negative rate of 1%.Covid-19No Covid-19SymptomaticAsymptomaticPCR (+)432199163PCR (−)179981198376030991010,000Proportion of PCR+ who are infected (PPV)39.2%Proportion of PCR− who are uninfected (NPV)99.7%P (Asymptomatic Covid-19, PCR+)13.0%P (Asymptomatic Covid-19, PCR−)0.09%

Conversely, assuming a false positive rate of 1%, only 39% of those who test positive would actually be infected. Therefore 61% of the swab-positive patients are likely to have elective procedures delayed even if they are not infected. An unknown proportion of these PCR-positive patients would also have Covid-19 symptoms but without having the disease.

This tool may aid managers and clinical leads tailor measures to prevent nosocomial spread of Covid-19 to their local conditions. This will allow a more appropriate balancing of the degree of infection control measures against the burden on patients and service capacity, to support maintenance of safe services. It may also help staff gain a clearer perspective of the probability of encountering PCR-negative asymptomatic Covid-19 patients.
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